Literature DB >> 30900173

Monitoring for Epigenetic Modifications at the FMR1 Locus.

Silvina Epsztejn-Litman1, Rachel Eiges2,3.   

Abstract

The vast majority of fragile X affected patients do not transcribe FMR1 due to a CGG repeat expansion in the 5'-untranslated region of the FMR1 gene. When the CGGs considerably expand, it elicits abnormal DNA methylation and histone modifications, which are responsible for FMR1 transcriptional silencing. In this chapter, we describe in detail two commonly used protocols for monitoring the epigenetic state of the FMR1 gene that bypass the difficulty in directly analyzing the CGGs. One protocol is for accurately measuring DNA methylation levels and the other is for profiling histone modifications.

Entities:  

Keywords:  Bisulfite DNA sequencing; Chromatin immune-precipitation (ChIP); DNA methylation; FMR1; Histone modifications; PCR; qPCR

Mesh:

Substances:

Year:  2019        PMID: 30900173     DOI: 10.1007/978-1-4939-9080-1_3

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  1 in total

1.  Genome-wide screening for genes involved in the epigenetic basis of fragile X syndrome.

Authors:  Dan Vershkov; Atilgan Yilmaz; Ofra Yanuka; Anders Lade Nielsen; Nissim Benvenisty
Journal:  Stem Cell Reports       Date:  2022-04-14       Impact factor: 7.294

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.